Alessia Bramanti
Alessia Bramanti has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Placido Bramanti
IRCCS Centro Neurolesi "Bonino-Pulejo", Messina, Italy
4 shared publications Antonino Naro
IRCCS Centro Neurolesi "Bonino-Pulejo", C.da Casazza SS. 113, Messina, Italy
2 shared publications- Pietro Lanzafame
IRCCS Centro Neurolesi, “Bonino-Pulejo
2 shared publications - Rocco Salvatore Calabrò
IRCCS Centro Neurolesi Bonino Pulejo, 98124 Messina, Italy
2 shared publications - Silvia Marino
IRCCS Centro Neurolesi Bonino-Pulejo, Messina, Italy; Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy
2 shared publications - Antonino Chillura
IRCCS Centro Neurolesi Messina, Messina, Italy,
1 shared publication
Latest Publications
- 4 July 2017
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 380, 46-50
The value of midbrain morphology in predicting prognosis in chronic disorders of consciousness: A preliminary ultrasound study
- 4 July 2017
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 380, 46-50
The value of midbrain morphology in predicting prognosis in chronic disorders of consciousness: A preliminary ultrasound study
- 1 April 2017
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 375, 3-7
Advances in assessing myotonia: Can sensor-engineered glove have a role?
- 1 April 2017
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 375, 3-7
Advances in assessing myotonia: Can sensor-engineered glove have a role?
- 21 August 2010
- Published by Springer Nature in Neurological Sciences
- Vol. 32 (1) , 67-71
Pursuit ocular movements in multiple sclerosis: a video-based eye-tracking study
Multiple sclerosis (MS) patients frequently develop some form of ocular motor dysfunction during the disease. In previous studies, ocular motor abnormalities were found to correlate with clinical disability and with impaired cognitive performance. The objective of this study was to assess the pursuit ocular movement (POM) frequency in relapsing–remitting (RR) and secondary progressive (SP) MS patients by using a vision-based non-intrusive eye tracker. POM frequency was significantly lower (p < 0.001) in MS patients compared to normal controls. No differences between RR and SP-MS patients and no correlation between POM and expanded disability status scale (EDSS) score were found. This exploratory study suggests that our vision-based system is a new simple non-intrusive method showing impairment of POM values in MS patients, even in the absence of association with clinical disability (EDSS). Future works on larger cohorts of MS patients might validate this eye tracking in MS clinical practice.
- 21 August 2010
- Published by Springer Nature in Neurological Sciences
- Vol. 32 (1) , 67-71
Pursuit ocular movements in multiple sclerosis: a video-based eye-tracking study
Multiple sclerosis (MS) patients frequently develop some form of ocular motor dysfunction during the disease. In previous studies, ocular motor abnormalities were found to correlate with clinical disability and with impaired cognitive performance. The objective of this study was to assess the pursuit ocular movement (POM) frequency in relapsing–remitting (RR) and secondary progressive (SP) MS patients by using a vision-based non-intrusive eye tracker. POM frequency was significantly lower (p < 0.001) in MS patients compared to normal controls. No differences between RR and SP-MS patients and no correlation between POM and expanded disability status scale (EDSS) score were found. This exploratory study suggests that our vision-based system is a new simple non-intrusive method showing impairment of POM values in MS patients, even in the absence of association with clinical disability (EDSS). Future works on larger cohorts of MS patients might validate this eye tracking in MS clinical practice.
- 19 November 2009
- Published by Springer Nature in Neurological Sciences
- Vol. 31 (3) , 381-385
The effect of l-Dopa administration on pursuit ocular movements in suspected Parkinson’s disease
The objective of this study is to evaluate pursuit ocular movements (POM) by using a vision-based non-intrusive eye tracker, in patients with suspected Parkinson’s disease (PD), before and after l-Dopa administration. We studied ten patients with suspected diagnosis of idiopathic PD. We compared POM values to those of a group of normal controls (NC), and evaluated them before and after l-Dopa administration. Unified Parkinson’s Disease Rating Scale (UPDRS) motor subscores improved significantly (p = 0.001). At baseline, values of POM were lower in suspected PD patients than in NC (p = 0.01). One hour after l-Dopa administration, POM values correlated with UPDRS motor subscore (p = 0.01). We used a recent method, a new vision-based non-intrusive eye tracker, previously described, which can be proposed as a possible tool for supporting the diagnosis of PD in association with levodopa test, as an add-on to the UPDRS score.
- 19 November 2009
- Published by Springer Nature in Neurological Sciences
- Vol. 31 (3) , 381-385
The effect of l-Dopa administration on pursuit ocular movements in suspected Parkinson’s disease
The objective of this study is to evaluate pursuit ocular movements (POM) by using a vision-based non-intrusive eye tracker, in patients with suspected Parkinson’s disease (PD), before and after l-Dopa administration. We studied ten patients with suspected diagnosis of idiopathic PD. We compared POM values to those of a group of normal controls (NC), and evaluated them before and after l-Dopa administration. Unified Parkinson’s Disease Rating Scale (UPDRS) motor subscores improved significantly (p = 0.001). At baseline, values of POM were lower in suspected PD patients than in NC (p = 0.01). One hour after l-Dopa administration, POM values correlated with UPDRS motor subscore (p = 0.01). We used a recent method, a new vision-based non-intrusive eye tracker, previously described, which can be proposed as a possible tool for supporting the diagnosis of PD in association with levodopa test, as an add-on to the UPDRS score.